← FDA Drug Approvals (Drugs@FDA)

NOREPINEPHRINE BITARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BIOCON PHARMA · Approved 2025-03-21

Drug application

FDA Application #

ANDA219443

Application type

Abbreviated New Drug Application (Generic)

Brand name

NOREPINEPHRINE BITARTRATE

Generic name

NOREPINEPHRINE BITARTRATE

Active ingredients

NOREPINEPHRINE BITARTRATE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

BIOCON PHARMA

Manufacturer

BIOCON PHARMA INC.

First approval

2025-03-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown